Response of letter to the Editor: "The impact of inflammation on the development, successful cardioversion, recurrence and/or perpetuation of atrial fibrillation", by Dr Hasan Turhan et al.

International Journal of Cardiology

Volumn 118, Issue 2, 2007, Pages 260-261

  Corbalan, Ramon ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Atrial fibrillation; C reactive protein; Cardioversion; Inflammation; Recurrence of AF

Indexed keywords

ANTIINFLAMMATORY AGENT; ASCORBIC ACID; C REACTIVE PROTEIN; CALCIUM CHANNEL; CELL PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; NEUROHORMONE; NONSTEROID ANTIINFLAMMATORY AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE;

ARTICLE; BIOACCUMULATION; CARDIOVERSION; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; INFLAMMATION; MOLECULAR MODEL; PRIORITY JOURNAL;

EID: 34247230116     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.029     Document Type: Article

References (22)

1. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
2. Acevedo M., Corbalan R., Braun S., Pereira J., Navarrete C., and Gonzalez I. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia". Int J Cardiol 108 3 (2006) 326-331
3. Dernellis J., and Panaretou M. C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol 56 6 (2001) 375-380
4. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 4 (1997) 1180-1184
5. Van Wagoner D.R. Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26 (2003) 1572-1575
6. Mihm M.J.P., Yu F.P., Carnes C.A.P.P., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. [Report]. Circulation 104 2 (July 10 2001) 174-180
7. Korantzopoulos P., Kolettis T., Siogas K., and Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9 (2002) RA225-RA229
8. Brundel B., Henning R.H., Kampinga H.H., Van Gelder I.C., and Crijns H. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res 54 (2002) 315-324
9. Dudley Jr. S.C., Hoch N.E., McCann L.A., et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112 (2005) 1266-1273
10. Psychari S.N., Apostolou T.S., Sinos L., Hamodraka E., Liakos G., and Kremastinos D.T. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 95 6 (2005) 764-767
11. Watanabe T., Takeishi Y., Hirono O., et al. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels 20 2 (2005) 45-49
12. Bruins P., Te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
13. Wazni O., Martin D.O., Marrouche N.F., et al. C-reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart 91 (2005) 1303-1305
14. Watanabe E., Arakawa T., Uchiyama T., Kodama I., and Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 108 3 (2006) 346-353
15. Malouf J.F., Kanagala R., Al Atawi F.O., et al. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 46 (2005) 1284-1287
16. Zhang H., Heerdt P.M., Park B., Fleisher M., and Thaler H.T. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest 128 (2005) 3421-3427
17. Kumagai K., Nakashima H., and Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 62 1 (Apr 1 2004) 105-111
18. Dernellis J., and Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 25 (2004) 1100-1107
19. Cheruku K.K., Ghani A., Ahmad F., et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 7 (2004) 13-18
20. Korantzopoulos P., Kolettis T.M., Kountouris E., et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 2 (2005) 321-326
21. Madrid A.H., Bueno M.G., Rebollo J.M., et al. Use of irbesartan to maintain sinus rhythm in patients with long lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 106 (2002) 331-336
22. Healey J.S., Morillo C.A., and Connolly S.J. Role of the rennin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling. Curr Opin Cardiol 20 1 (Jan 2005) 31-37